Fmoc-Ala-Ala-Asn(Trt)-OH is a protected tripeptide building block optimized for solid-phase peptide synthesis. The Fmoc group controls N-terminal reactivity, while the trityl-protected asparagine side chain prevents undesired cyclization or deamidation. Alanine residues provide a neutral, helix-supporting backbone segment. Researchers use this reagent to construct Asn-containing motifs, loops, and recognition sites in longer sequences.
CAT No: R2597
CAS No:1951424-92-2
Synonyms/Alias:Fmoc-Ala-Ala-Asn(Trt)-OH;1951424-92-2;FMc-Ala-Ala-Asn(Trt)-OH;(2S)-2-[(2S)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]propanamido]-3-[(triphenylmethyl)carbamoyl]propanoic acid;AKOS040743314;BP-20374;HY-130933;CS-0119078;G86808;(5S,8S,11S)-1-(9H-Fluoren-9-yl)-5,8-dimethyl-3,6,9-trioxo-11-(2-oxo-2-(tritylamino)ethyl)-2-oxa-4,7,10-triazadodecan-12-oic acid;
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.